Treatment with ruxolitinib cream resulted in significant disease control over 52 weeks in a subset of children with moderate/more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback